{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:49:08Z","timestamp":1785876548591,"version":"3.56.0"},"reference-count":105,"publisher":"Elsevier","isbn-type":[{"value":"9780443345258","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.irn.2026.05.014","type":"book-chapter","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T20:44:48Z","timestamp":1780001088000},"page":"113-143","source":"Crossref","is-referenced-by-count":0,"title":["Molecular insights of peroxisome proliferator-activated receptor-\u03b3 signalling in amyotrophic lateral sclerosis and Huntington\u2019s disease"],"prefix":"10.1016","author":[{"given":"Gopika","family":"Venu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh Pandi","family":"A","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Justin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/bs.irn.2026.05.014_bib1","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3390\/antiox12051075","article-title":"PGC-1\u03b1 Is a master regulator of mitochondrial lifecycle and ROS stress response","volume":"12","author":"Abu Shelbayeh","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/bs.irn.2026.05.014_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/806306","article-title":"ALS and frontotemporal dysfunction: A review","volume":"2012","author":"Achi","year":"2012","journal-title":"Neurology Research International"},{"key":"10.1016\/bs.irn.2026.05.014_bib3","unstructured":"Ajitkumar, A., Lui, F., & De Jesus, O. (2025, April 6). Huntington disease. In StatPearls [Internet]. StatPearls Publishing. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559166\/."},{"key":"10.1016\/bs.irn.2026.05.014_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2023\/9296092","article-title":"The molecular basis of Wnt\/\u03b2-catenin signaling pathways in neurodegenerative diseases","volume":"2023","author":"Anand","year":"2023","journal-title":"International Journal of Cell Biology"},{"issue":"11","key":"10.1016\/bs.irn.2026.05.014_bib5","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.3390\/ijms25115587","article-title":"Revisiting glutamate excitotoxicity in amyotrophic lateral sclerosis and age-related neurodegeneration","volume":"25","author":"Arnold","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.irn.2026.05.014_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216662","article-title":"The interplay between autophagy and apoptosis: Its implication in lung cancer and therapeutics","volume":"585","author":"Biswas","year":"2024","journal-title":"Cancer Letters"},{"key":"10.1016\/bs.irn.2026.05.014_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fncel.2017.00080","article-title":"ALS pathogenesis and therapeutic approaches: The role of mesenchymal stem cells and extracellular vesicles","volume":"11","author":"Bonafede","year":"2017","journal-title":"Frontiers in Cellular Neuroscience"},{"key":"10.1016\/bs.irn.2026.05.014_bib8","first-page":"46","article-title":"Amyotrophic lateral sclerosis: Integrated care provides the best quality of life","volume":"18","author":"Brent","year":"2019","journal-title":"Practical neurology (Fort Washington, Pa)"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.014_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/658520","article-title":"PPAR regulation of inflammatory signaling in CNS diseases","volume":"2008","author":"Bright","year":"2008","journal-title":"PPAR Research"},{"key":"10.1016\/bs.irn.2026.05.014_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pneurobio.2017.10.002","article-title":"Peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3): A master gatekeeper in CNS injury and repair","volume":"163\u2013164","author":"Cai","year":"2018","journal-title":"Progress in Neurobiology"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.014_bib11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3390\/ijms22020805","article-title":"PPAR gamma: From definition to molecular targets and therapy of lung diseases","volume":"22","author":"Carvalho","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.014_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41420-024-02278-8","article-title":"Free radicals and their impact on health and antioxidant defenses: A review","volume":"11","author":"Chandimali","year":"2025","journal-title":"Cell Death Discovery"},{"issue":"20","key":"10.1016\/bs.irn.2026.05.014_bib13","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/hmg\/ddq322","article-title":"Modulation of energy deficiency in Huntington\u2019s disease via activation of the peroxisome proliferator-activated receptor gamma","volume":"19","author":"Chiang","year":"2010","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.014_bib14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.nbd.2011.08.016","article-title":"PPARgamma rescue of the mitochondrial dysfunction in Huntington\u2019s disease","volume":"45","author":"Chiang","year":"2012","journal-title":"Neurobiology of Disease"},{"issue":"9","key":"10.1016\/bs.irn.2026.05.014_bib15","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.bbadis.2011.05.006","article-title":"The dysfunction of hepatic transcriptional factors in mice with Huntington\u2019s Disease","volume":"1812","author":"Chiang","year":"2011","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.014_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2014.117","article-title":"Degradation of misfolded proteins in neurodegenerative diseases: Therapeutic targets and strategies","volume":"47","author":"Ciechanover","year":"2015","journal-title":"Experimental & Molecular Medicine"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.014_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/dgd.12718","article-title":"Wnt\/\u03b2\u2010catenin signaling: Structure, assembly and endocytosis of the signalosome","volume":"63","author":"Colozza","year":"2021","journal-title":"Development, Growth & Differentiation"},{"key":"10.1016\/bs.irn.2026.05.014_bib18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2016.06.023","article-title":"PPAR\u03b3 as a therapeutic target to rescue mitochondrial function in neurological disease","volume":"100","author":"Corona","year":"2016","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/bs.irn.2026.05.014_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/409168","article-title":"PPARG: Gene expression regulation and next-generation sequencing for unsolved issues","volume":"2010","author":"Costa","year":"2010","journal-title":"PPAR Research"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.014_bib20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.15171\/apb.2019.003","article-title":"Crosstalk between peroxisome proliferator-activated receptors andtoll-like receptors: A systematic review","volume":"9","author":"Dana","year":"2019","journal-title":"Advanced Pharmaceutical Bulletin"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.014_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.apsb.2024.10.004","article-title":"Oxidative stress and inflammation in the pathogenesis of neurological disorders: Mechanisms and implications","volume":"15","author":"Dash","year":"2025","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"6","key":"10.1016\/bs.irn.2026.05.014_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037885","article-title":"A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis","volume":"7","author":"Dupuis","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.014_bib23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s13311-012-0112-2","article-title":"Huntington\u2019s disease and the striatal medium spiny neuron: Cell-autonomous and non-cell-autonomous mechanisms of disease","volume":"9","author":"Ehrlich","year":"2012","journal-title":"Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.014_bib24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: A review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicologic Pathology"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.014_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/704165","article-title":"PPAR \u03b3 and apoptosis in cancer","volume":"2008","author":"Elrod","year":"2008","journal-title":"PPAR Research"},{"issue":"10360","key":"10.1016\/bs.irn.2026.05.014_bib26","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"The Lancet"},{"key":"10.1016\/bs.irn.2026.05.014_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102357","article-title":"Neurodegenerative disorders: Mechanisms of degeneration and therapeutic approaches with their clinical relevance","volume":"99","author":"Gadhave","year":"2024","journal-title":"Ageing Research Reviews"},{"issue":"6","key":"10.1016\/bs.irn.2026.05.014_bib28","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1124\/mol.106.033845","article-title":"The thiazolidinedione pioglitazone alters mitochondrial function in human neuron-like cells","volume":"71","author":"Ghosh","year":"2007","journal-title":"Molecular Pharmacology"},{"issue":"12","key":"10.1016\/bs.irn.2026.05.014_bib29","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1210\/me.2002-0020","article-title":"Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter","volume":"16","author":"Girnun","year":"2002","journal-title":"Molecular Endocrinology"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.014_bib30","first-page":"647","article-title":"Pathophysiology, clinical heterogeneity, and therapeutic advances in amyotrophic lateral sclerosis: A comprehensive review of molecular mechanisms, diagnostic challenges, and multidisciplinary management strategies","volume":"15","author":"Gonz\u00e1lez-S\u00e1nchez","year":"2025","journal-title":"Life (Chicago, Ill.: 1978)"},{"issue":"11\u201312","key":"10.1016\/bs.irn.2026.05.014_bib31","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.bbadis.2006.01.004","article-title":"Genetics of familial and sporadic amyotrophic lateral sclerosis","volume":"1762","author":"Gros-Louis","year":"2006","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"issue":"7","key":"10.1016\/bs.irn.2026.05.014_bib32","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3390\/antiox14070848","article-title":"Manganese superoxide dismutase: Structure, function, and implications in human disease","volume":"14","author":"Grujicic","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/bs.irn.2026.05.014_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1687698","article-title":"Comparative safety analysis of riluzole, edaravone and tofersen in ALS management: Insights from FAERS database","volume":"16","author":"Guan","year":"2025","journal-title":"Frontiers in Pharmacology"},{"issue":"7","key":"10.1016\/bs.irn.2026.05.014_bib34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.tcb.2011.03.007","article-title":"Autophagy and apoptosis: What is the connection?","volume":"21","author":"Gump","year":"2011","journal-title":"Trends in Cell Biology"},{"key":"10.1016\/bs.irn.2026.05.014_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177750","article-title":"Regulating peroxisome proliferator activated receptor gamma coactivator-1alpha (PGC-1\u03b1): A potential role in neurological disorder and treatment","volume":"1001","author":"Guo","year":"2025","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2026.05.014_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2019.104604","article-title":"Neuroprotective potential of azilsartan against cerebral ischemic injury: Possible involvement of mitochondrial mechanisms","volume":"132","author":"Gupta","year":"2020","journal-title":"Neurochemistry International"},{"key":"10.1016\/bs.irn.2026.05.014_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2023\/6422804","article-title":"Peroxisome proliferator-activated receptor \u03b3 regulates lipid metabolism in sheep trophoblast cells through mTOR pathway-mediated autophagy","volume":"2023","author":"Hao","year":"2023","journal-title":"PPAR Research"},{"issue":"10","key":"10.1016\/bs.irn.2026.05.014_bib38","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.180116","article-title":"Wnt signalling in the development of axon, dendrites and synapses","volume":"8","author":"He","year":"2018","journal-title":"Open Biology"},{"issue":"17","key":"10.1016\/bs.irn.2026.05.014_bib39","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1111\/febs.14970","article-title":"Apoptotic cell death regulation in neurons","volume":"286","author":"Hollville","year":"2019","journal-title":"The FEBS Journal"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.014_bib40","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/ncomms2270","article-title":"PPAR\u03b3 is an E3 ligase that induces the degradation of NF\u03baB\/p65","volume":"3","author":"Hou","year":"2012","journal-title":"Nature Communications"},{"issue":"22","key":"10.1016\/bs.irn.2026.05.014_bib41","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202502727R","article-title":"Recent advancements in the research of the mechanism by which PPAR\u00a0\u2010\u03b3 Is involved in postoperative neurocognitive disorder","volume":"39","author":"Huang","year":"2025","journal-title":"The FASEB Journal"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.014_bib42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajme.2017.09.001","article-title":"First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid","volume":"54","author":"Ighodaro","year":"2018","journal-title":"Alexandria Journal of Medicine"},{"issue":"10","key":"10.1016\/bs.irn.2026.05.014_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12101389","article-title":"Pathogenesis of Huntington\u2019s disease: An emphasis on molecular pathways and prevention by natural remedies","volume":"12","author":"Irfan","year":"2022","journal-title":"Brain Sciences"},{"key":"10.1016\/bs.irn.2026.05.014_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107705","article-title":"PPAR\u03b3\/PGC1\u03b1 signaling as a potential therapeutic target for mitochondrial biogenesis in neurodegenerative disorders","volume":"219","author":"Jamwal","year":"2021","journal-title":"Pharmacology & Therapeutics"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.014_bib45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.15171\/apb.2019.024","article-title":"Understanding apoptosis and apoptotic pathways targeted cancer therapeutics","volume":"9","author":"Jan","year":"2019","journal-title":"Advanced Pharmaceutical Bulletin"},{"issue":"7","key":"10.1016\/bs.irn.2026.05.014_bib46","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a024240","article-title":"Huntington\u2019s disease: Mechanisms of pathogenesis and therapeutic strategies","volume":"7","author":"Jimenez-Sanchez","year":"2017","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.014_bib47","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/jnc.12190","article-title":"Neuroprotective effects of PPAR-\u03b3 agonist rosiglitazone in N171-82Q mouse model of Huntington\u2019s disease","volume":"125","author":"Jin","year":"2013","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.irn.2026.05.014_bib48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.freeradbiomed.2013.04.016","article-title":"PGC-1\u03b1, mitochondrial dysfunction, and Huntington\u2019s disease","volume":"62","author":"Johri","year":"2013","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/bs.irn.2026.05.014_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117827","article-title":"The role of mitochondrial dysfunction in Huntington\u2019s disease: Implications for therapeutic targeting","volume":"183","author":"Joshi","year":"2025","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"6","key":"10.1016\/bs.irn.2026.05.014_bib50","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/md17060321","article-title":"An Algal metabolite-based PPAR-\u03b3 agonist displayed anti-inflammatory effect via inhibition of the NF-\u03baB pathway","volume":"17","author":"Ju","year":"2019","journal-title":"Marine Drugs"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.014_bib51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pbb.2010.04.018","article-title":"Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: Possible role of peroxisome proliferator activated receptor-\u03d2 (PPAR\u03d2) in Huntington\u2019s disease","volume":"96","author":"Kalonia","year":"2010","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.014_bib52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10787-024-01635-4","article-title":"Stimulation, regulation, and inflammaging interventions of natural compounds on nuclear factor kappa B (NF-kB) pathway: A comprehensive review","volume":"33","author":"Kannan","year":"2025","journal-title":"Inflammopharmacology"},{"issue":"7","key":"10.1016\/bs.irn.2026.05.014_bib53","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3390\/cells8070674","article-title":"A comprehensive review of autophagy and its various roles in infectious, non-infectious, and lifestyle diseases: Current knowledge and prospects for disease prevention, novel drug design, and therapy","volume":"8","author":"Khandia","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.014_bib54","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/418765","article-title":"Peroxisome proliferator\u2010activated receptor\u2010\u03b3 in amyotrophic lateral sclerosis and Huntington\u2032s disease","volume":"2008","author":"Kiaei","year":"2008","journal-title":"PPAR Research"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.014_bib55","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.expneurol.2004.10.007","article-title":"Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis","volume":"191","author":"Kiaei","year":"2005","journal-title":"Experimental Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.014_bib56","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3349\/ymj.2013.54.3.545","article-title":"Modulation of the transcriptional activity of peroxisome proliferator-activated receptor gamma by protein-protein interactions and post-translational modifications","volume":"54","author":"Kim","year":"2013","journal-title":"Yonsei Medical Journal"},{"issue":"6","key":"10.1016\/bs.irn.2026.05.014_bib57","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00011-019-01231-1","article-title":"Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors","volume":"68","author":"Korbecki","year":"2019","journal-title":"Inflammation Research"},{"key":"10.1016\/bs.irn.2026.05.014_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/816856","article-title":"Review of the structural and dynamic mechanisms of PPAR \u03b3 partial agonism","volume":"2015","author":"Kroker","year":"2015","journal-title":"PPAR Research"},{"key":"10.1016\/bs.irn.2026.05.014_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/5879090","article-title":"Interactions between PPAR gamma and the canonical Wnt\/beta-catenin pathway in type 2 diabetes and colon cancer","volume":"2017","author":"Lecarpentier","year":"2017","journal-title":"PPAR Research"},{"key":"10.1016\/bs.irn.2026.05.014_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2016.00100","article-title":"Opposite Interplay between PPAR gamma and canonical Wnt\/Beta-catenin pathway in amyotrophic lateral sclerosis","volume":"7","author":"Lecarpentier","year":"2016","journal-title":"Frontiers in Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.014_bib61","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1378175","article-title":"Collaborative power of Nrf2 and PPAR \u03b3 activators against metabolic and drug\u2010induced oxidative injury","volume":"2017","author":"Lee","year":"2017","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.014_bib62","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40035-025-00505-5","article-title":"Molecular mechanisms of mitochondrial quality control","volume":"14","author":"Li","year":"2025","journal-title":"Translational Neurodegeneration"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.014_bib63","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1152\/advan.00052.2006","article-title":"PGC-1\u03b1: A key regulator of energy metabolism","volume":"30","author":"Liang","year":"2006","journal-title":"Advances in Physiology Education"},{"issue":"15","key":"10.1016\/bs.irn.2026.05.014_bib64","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1128\/MCB.00441-06","article-title":"Functional interaction between peroxisome proliferator-activated receptor \u03b3 and \u03b2-catenin","volume":"26","author":"Liu","year":"2006","journal-title":"Molecular and Cellular Biology"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.014_bib65","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/\u03b2-catenin signalling: Function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.014_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"33","key":"10.1016\/bs.irn.2026.05.014_bib67","doi-asserted-by":"crossref","first-page":"28858","DOI":"10.1074\/jbc.M111.273292","article-title":"Peroxisome proliferator-activated receptor \u03b3 induces apoptosis and inhibits autophagy of human monocyte-derived macrophages via induction of cathepsin L","volume":"286","author":"Mahmood","year":"2011","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.014_bib68","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41418-019-0290-0","article-title":"Therapeutic modulation of autophagy: Which disease comes first?","volume":"26","author":"Maiuri","year":"2019","journal-title":"Cell Death & Differentiation"},{"issue":"11","key":"10.1016\/bs.irn.2026.05.014_bib69","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.3390\/biom14111445","article-title":"Exploring PPAR gamma and PPAR Alpha\u2019s regulation role in metabolism via epigenetics mechanism","volume":"14","author":"Ma\u0142odobra-Mazur","year":"2024","journal-title":"Biomolecules"},{"issue":"11","key":"10.1016\/bs.irn.2026.05.014_bib70","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1007\/s11064-021-03402-1","article-title":"Peroxisome proliferator-activated receptor-gamma (PPAR-\u0263): Molecular effects and its importance as a novel therapeutic target for cerebral ischemic injury","volume":"46","author":"Mannan","year":"2021","journal-title":"Neurochemical Research"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.014_bib71","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-pharmtox-010818-021807","article-title":"Nuclear receptors as therapeutic targets for neurodegenerative diseases: Lost in translation","volume":"59","author":"Moutinho","year":"2019","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/bs.irn.2026.05.014_bib72","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/B978-0-12-417158-9.00005-4","article-title":"Apoptosis initiation through the cell-extrinsic pathway","author":"Nair","year":"2014","journal-title":"Methods in Enzymology"},{"issue":"9","key":"10.1016\/bs.irn.2026.05.014_bib73","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3390\/antiox9090901","article-title":"Oxidative stress, neuroinflammation and mitochondria in the pathophysiology of amyotrophic lateral sclerosis","volume":"9","author":"Obrador","year":"2020","journal-title":"Antioxidants"},{"issue":"12","key":"10.1016\/bs.irn.2026.05.014_bib74","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1161\/CIRCRESAHA.116.306588","article-title":"Heme oxygenase-1 and carbon monoxide in the heart","volume":"118","author":"Otterbein","year":"2016","journal-title":"Circulation Research"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.014_bib75","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","article-title":"Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease","volume":"8","author":"Panwar","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"9","key":"10.1016\/bs.irn.2026.05.014_bib76","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3390\/diagnostics11091546","article-title":"Oxidative stress as a therapeutic target in amyotrophic lateral sclerosis: Opportunities and limitations","volume":"11","author":"Park","year":"2021","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.014_bib77","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12974-024-03173-w","article-title":"PPAR\u03b3 activation ameliorates cognitive impairment and chronic microglial activation in the aftermath of r-mTBI","volume":"21","author":"Pearson","year":"2024","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/bs.irn.2026.05.014_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1147414","article-title":"Research progress of glutathione peroxidase family (GPX) in redoxidation","volume":"14","author":"Pei","year":"2023","journal-title":"Frontiers in Pharmacology"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.014_bib79","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.3390\/ijms24043201","article-title":"Development of PPAR\u03b3 agonists for the treatment of neuroinflammatory and neurodegenerative diseases: Leriglitazone as a promising candidate","volume":"24","author":"Pizcueta","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.irn.2026.05.014_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/641087","article-title":"PPAR and oxidative stress: Con catenating NRF2 and FOXO","volume":"2012","author":"Polvani","year":"2012","journal-title":"PPAR Research"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.014_bib81","first-page":"3743","article-title":"Differential peroxisome proliferator activated receptors activity in a rodent model of amyotrophic lateral sclerosis","volume":"8","author":"Qi","year":"2015","journal-title":"International Journal of Clinical and Experimental Medicine"},{"issue":"37","key":"10.1016\/bs.irn.2026.05.014_bib82","doi-asserted-by":"crossref","first-page":"25628","DOI":"10.1074\/jbc.M804291200","article-title":"Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells","volume":"283","author":"Quintanilla","year":"2008","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.irn.2026.05.014_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/768594","article-title":"Role of PPAR \u03b3 in the differentiation and function of neurons","volume":"2014","author":"Quintanilla","year":"2014","journal-title":"PPAR Research"},{"issue":"12","key":"10.1016\/bs.irn.2026.05.014_bib84","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.freeradbiomed.2008.09.002","article-title":"PPAR\u03b1 ligands inhibit radiation-induced microglial inflammatory responses by negatively regulating NF-\u03baB and AP-1 pathways","volume":"45","author":"Ramanan","year":"2008","journal-title":"Free Radical Biology and Medicine"},{"issue":"10","key":"10.1016\/bs.irn.2026.05.014_bib85","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.3390\/molecules27103194","article-title":"Neuroinflammatory markers: Key indicators in the pathology of neurodegenerative diseases","volume":"27","author":"Rauf","year":"2022","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"8","key":"10.1016\/bs.irn.2026.05.014_bib86","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.bbalip.2007.02.013","article-title":"PPARs and molecular mechanisms of transrepression","volume":"1771","author":"Ricote","year":"2007","journal-title":"Biochimica et Biophysica Acta (BBA)\u00a0- Molecular and Cell Biology of Lipids"},{"issue":"12","key":"10.1016\/bs.irn.2026.05.014_bib87","article-title":"A review of oral fixed-dose sodium phenylbutyrate and ursodoxicoltaurine in people with amyotrophic lateral sclerosis","volume":"2","author":"Roberts","year":"2023","journal-title":"EMJ Neurology"},{"issue":"9","key":"10.1016\/bs.irn.2026.05.014_bib88","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.3390\/antiox12091747","article-title":"Insights on the multifaceted roles of wild-type and mutated superoxide dismutase 1 in amyotrophic lateral sclerosis pathogenesis","volume":"12","author":"Rubino","year":"2023","journal-title":"Antioxidants"},{"issue":"34","key":"10.1016\/bs.irn.2026.05.014_bib89","doi-asserted-by":"crossref","first-page":"7805","DOI":"10.1523\/JNEUROSCI.2038-05.2005","article-title":"The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice","volume":"25","author":"Sch\u00fctz","year":"2005","journal-title":"The Journal of Neuroscience"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.014_bib90","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","article-title":"Regulation of apoptosis in health and disease: The balancing act of BCL-2 family proteins","volume":"20","author":"Singh","year":"2019","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.014_bib91","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13024-020-00397-1","article-title":"The role of TDP-43 mislocalization in amyotrophic lateral sclerosis","volume":"15","author":"Suk","year":"2020","journal-title":"Molecular Neurodegeneration"},{"issue":"7","key":"10.1016\/bs.irn.2026.05.014_bib92","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1474-4422(22)00121-1","article-title":"Potential disease-modifying therapies for Huntington\u2019s disease: Lessons learned and future opportunities","volume":"21","author":"Tabrizi","year":"2022","journal-title":"The Lancet Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2026.05.014_bib93","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.neuron.2019.01.039","article-title":"Huntingtin lowering strategies for disease modification in Huntington\u2019s disease","volume":"101","author":"Tabrizi","year":"2019","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/bs.irn.2026.05.014_bib94","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00401-012-1005-5","article-title":"Coexistence of Huntington\u2019s disease and amyotrophic lateral sclerosis: A clinicopathologic study","volume":"124","author":"Tada","year":"2012","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/bs.irn.2026.05.014_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1454735","article-title":"Study insights in the role of PGC-1\u03b1 in neurological diseases: Mechanisms and therapeutic potential","volume":"16","author":"Tang","year":"2025","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"7","key":"10.1016\/bs.irn.2026.05.014_bib96","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.3390\/ijms25073845","article-title":"Huntington\u2019s disease: Complex pathogenesis and therapeutic strategies","volume":"25","author":"Tong","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.irn.2026.05.014_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/937123","article-title":"Regulation of PPAR \u03b3\u00a0coactivator-1 \u03b1\u00a0function and expression in muscle: Effect of exercise","volume":"2010","author":"Uguccioni","year":"2010","journal-title":"PPAR Research"},{"issue":"35","key":"10.1016\/bs.irn.2026.05.014_bib98","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.2174\/1381612820666140305224906","article-title":"Mitochondrial biogenesis: A therapeutic target for neurodevelopmental disorders and neurodegenerative diseases","volume":"20","author":"Uittenbogaard","year":"2014","journal-title":"Current Pharmaceutical Design"},{"issue":"6","key":"10.1016\/bs.irn.2026.05.014_bib99","doi-asserted-by":"crossref","first-page":"605","DOI":"10.4062\/biomolther.2021.012","article-title":"Neuronal autophagy: Characteristic features and roles in neuronal pathophysiology","volume":"29","author":"Valencia","year":"2021","journal-title":"Biomolecules & Therapeutics"},{"key":"10.1016\/bs.irn.2026.05.014_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00745","article-title":"Crosstalk between peroxisome proliferator-activated receptor gamma and the canonical WNT\/\u03b2-catenin pathway in chronic inflammation and oxidative stress during carcinogenesis","volume":"9","author":"Vall\u00e9e","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.irn.2026.05.014_bib101","series-title":"Amyotrophic Lateral Sclerosis","first-page":"1","article-title":"Clinical manifestation and management of amyotrophic lateral sclerosis","author":"Verma","year":"2021"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.014_bib102","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10571-017-0554-5","article-title":"Roles of peroxisome proliferator-activated receptor gamma on brain and peripheral inflammation","volume":"38","author":"Villapol","year":"2018","journal-title":"Cellular and Molecular Neurobiology"},{"key":"10.1016\/bs.irn.2026.05.014_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.00110","article-title":"Microglia and Wnt pathways: Prospects for inflammation in Alzheimer\u2019s disease","volume":"12","author":"Yang","year":"2020","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.014_bib104","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/biom14020190","article-title":"PPAR\u03b3 modulators in lung cancer: Molecular mechanisms, clinical prospects, and challenges","volume":"14","author":"Zhang","year":"2024","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.014_bib105","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3390\/cells12040668","article-title":"Autophagosome biogenesis","volume":"12","author":"Zhen","year":"2023","journal-title":"Cells"}],"container-title":["International Review of Neurobiology","Brain Energy Metabolism in Alzheimers Disease - Part C"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774226000437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774226000437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:16:48Z","timestamp":1785874608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774226000437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443345258"],"references-count":105,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2026.05.014","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}